| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.3 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.055 | 0.3 |